{"name":"Pathalys Pharma","slug":"pathalys-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPb3MxS1JoS3BkX2l1Ukd4ZlZ1R0xrV1M2aVNUUkFQMTJuQVo3SmoxVWs5NkZWVUIwU0tsNTRTaV8tXzUtaFJhVThfWWM0dXFRNmE3RmotbTZJVDQyblBsOWVwTGgzQkFTeXA5Y2k1cFFtRWVhZ0NFdjlXQmwyUW1mQ2F6MjF5QVJiUzQwSnNuWHRRb283WXZTd0FYd0E1RnFoQ3dCTUdIYm5OVHM0UGExeVlMWVIwcW04bW1ZUkFkNmtNXy1RblVtQnlacDMzMmViRUdHY0xhdUI2TnZRekpMZQ?oc=5","date":"2024-08-27","type":"pipeline","source":"Wilson Sonsini","summary":"Wilson Sonsini Advises JP Morgan Life Sciences Private Capital on Pathalys Pharma’s $105 Million Series B - Wilson Sonsini","headline":"Wilson Sonsini Advises JP Morgan Life Sciences Private Capital on Pathalys Pharma’s $105 Million Series B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQSnYwVEluVFQzVVlDRDB5dzlLeGttZjR1T0JGR3FYVDBQMGxFNHF3TmRRU2xHM1YzbVZEZ0RHeU1ZSTRFakQ0LUZ4dlZsREN3NEJpLWtCQm5QeW1qRXR3QVdNWmY4b3d3NlpLLXBLWVNpWl8tN3ZGWTVuNzBpa2pTM0xvRm9XR2x3OGRlYmhLVVdONkNYUXNLNC1fck9KbFZPS0o0Y1VFUmItV3c?oc=5","date":"2024-08-21","type":"regulatory","source":"Pharmaceutical Technology","summary":"Pathalys secures $105m to advance SHPT drug through approval - Pharmaceutical Technology","headline":"Pathalys secures $105m to advance SHPT drug through approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOLVl6bTBfckxFSUtndzNRTThxeHp1ZW5SRm9PSjVCVE82OXA2ejd2NEhxOWJRRHk1SVNsOXRRd3o1SU9LNGNfd0dILXk1dU5sTlA5a1p2Tm9ndjhCSHgyLWVBalpkcG5lVFBmVC1KeS1DZjMybkNzZGVPeHVfeXNhc1g2M3hrSmFRTThGQXVraVNzMzlYbWRRVENlSTFYTXJfTjRYc1R6RThodEM1aExJ?oc=5","date":"2024-08-20","type":"pipeline","source":"PR Newswire","summary":"Pathalys Pharma Secures $105 Million Series B Financing - PR Newswire","headline":"Pathalys Pharma Secures $105 Million Series B Financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOYmItQ1IxcUlOTnJVTEh1V01DZGZ6N0lqN1IyNTdqMElwWlNZWUR2a21rSG41SEtwQjByOE9OSFlwcVhqN3ZjMXVlSFk2NVJUN1JFRXJfa2lVaWJhcVlUNG9oSUd0bnFGMHo1ZVV4WndEem1RMWJrNzhWNjN6cFRHV2Q0V3pNX0hvRWc4R1p3LWViaHFGa1RUVFh5djAzUzZLTVFZamMzb29aN1FNVVI0aHlLeHQ?oc=5","date":"2024-08-20","type":"regulatory","source":"Fierce Biotech","summary":"Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA - Fierce Biotech","headline":"Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQM2lEaDVTY2p2cWVlZmZRQWloS0w5RXJNZXIwWE5ib1RvRjBuSW5oWXpvNEJ0UmpLNnJuZnVWWVBlUGpOV19GMnZxRjc5SWJrRlJURl9oUGtCTkFlUFJtYWpVVmVTaWFUNGVlU0V3NTFORVE1SlJWNV9Obm1MLW4tRHJLRmxnWTNRR3ZSTTdrQ1YyTmhvU1VraFRGZzlWanZacDNFdHVub05JRG8?oc=5","date":"2024-08-14","type":"pipeline","source":"Contract Pharma","summary":"Pathalys Pharma Names Bastian Dehmel as Chief Medical Officer - Contract Pharma","headline":"Pathalys Pharma Names Bastian Dehmel as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPX1ZnMG9ac1l1NUVqWk10cTFLbEFpV0VYeEppQVJVbG1WbW96YjloX2dPOHNvcTZjbEZVRHFLQzY5RzF6Vk1MNF9zTVNiTWx6VHpITUIyX0lBUEdhOFFpRV94R2tHOVBwTlpOOGZDWmMxdjZqaTZiOVllZVV0YmpYV3hLazN6Ql95MTFFZTZwX3dwVWsxN0prY0k2WUZtdHI4ODB3M0s4MnNWa1BLY294SlpwbmpMTHpoTElaWTNaLWk?oc=5","date":"2024-08-13","type":"pipeline","source":"PR Newswire","summary":"Pathalys Pharma Appoints Dr. Bastian Dehmel as Chief Medical Officer - PR Newswire","headline":"Pathalys Pharma Appoints Dr. Bastian Dehmel as Chief Medical Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxNQlNoeFBPWUJYS0drYTBOU1ZLQ0tKRmFHM0NXVmVPckg1N2l5NFkzdlVScHlkRVpPRld4c05meVJkVG90aGRNemJwbUxaUEZoWDliT0lTY24teEpDWUl4WHhmaEtRMVNVeFpqSjRsa3pyU2hZSjB4U1lyMXJjTl9mTU1kbVU0Z1VhcWxVNW9FQXhkdWNCdjkwV3NXNlBxbGtoZWRHNzg4YW43YWg3TnZSNEppemhnTnNNQXg1WTktaGlKUDYwblFXMjZLbkExdVRXTF8zYWMyamJvMmNWOWdpeTVmOE8zRFlwWndfY2lHckJjN0hkSkhtY1RBS1Q5cHVab2pGTThOdl9LSFBXc0o1bXdnU21zTzlYWDdmU2oyQjFNWEpUR1B4SFBWUVdlOWZ1ZEtNSFg2djl5d19TUzJRVlZ6QmxWUQ?oc=5","date":"2023-05-31","type":"trial","source":"PR Newswire","summary":"Pathalys Pharma and Launch Therapeutics Announce First Patient Enrolled Ahead of Schedule in Pivotal Phase 3 Program for Upacicalcet in Patients Receiving Hemodialysis - PR Newswire","headline":"Pathalys Pharma and Launch Therapeutics Announce First Patient Enrolled Ahead of Schedule in Pivotal Phase 3 Program for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxPRkdsbExjZFV0ektUTXRTYldxMTI5ZUZGX2hkWDZ5dW10NHdIc0xhRjU0Tmk5cGtESmxxdFduUnR3T2xIamRic1kzRWJ0ZkxtYWpWbHl3N3V5RHRBSW9DV2J1X1JtTHB6M3FLdV9UNnB2eUtJamhReGFFai1PU0N3WkoxckttaGZ4S3BPd3NUd0dFY3EyX1FuMG1jV0NzNmdKZTZWbkpPZzJYNG5pUmxEdHhkQXFBSzF1WU5YbU43X3R6ZE05T3NBaE5qU0RwY2JoM3R2cQ?oc=5","date":"2023-01-24","type":"deal","source":"connectmoney.com","summary":"Pathalys Pharma Raises $150M Led by Abingworth; Forms Strategic Collaboration with Launch Therapeutics - connectmoney.com","headline":"Pathalys Pharma Raises $150M Led by Abingworth; Forms Strategic Collaboration with Launch Therapeutics","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-01-18","type":"trial","source":"PR Newswire","summary":"Pathalys Pharma Raises $150 Million in Secured Product Financing and Equity led by Abingworth; Forms Strategic Collaboration with Launch Therapeutics to Advance Upacicalcet through Pivotal Phase 3 Stu","headline":"Pathalys Pharma Raises $150 Million in Secured Product Financing and Equity led by Abingworth; Forms Strategic Collabora","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxNZ2p4TjR3THdaTWZCUGtiOUhIOWZYa2dJeThqOFM3cW45ZUFQbEtmRkJrQ2R1ZEMxUmJEbjFTVFlsRFU3TE1KM2o2X0dublFmSlJBek9YZ3RIeURwaGJ2bHNyb1J4VjNNbmhHOFNoaTQ4ZnJmdjJFcTg3Qzl3QnNPWC03RDdQTVZuY2V2MHpuVVdISWNaUmdweVg5bEJ0UUJISklYWG9FM0l6VldsaDhHejZlMA?oc=5","date":"2022-04-07","type":"trial","source":"PR Newswire","summary":"Pathalys Pharma Announces Phase 3 Program for Upacicalcet - PR Newswire","headline":"Pathalys Pharma Announces Phase 3 Program for Upacicalcet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOQVlyUGREWDlVWE1MbTZNNHc3bnBaZjhKOXp6VDVyWW42STUyTHk4TVUtNjVGMWxZbkRZMlRURXNBSXVSZ1VOSVNhNkppbUNuUFRKWXVhaDA3OTN4dVRhdDRQODBsa1k4cDl4STdEM2VxNk1PWks5ZmdpUEtMSm1JcTRSZlkyYkNZbHh3c01STzJnNXNnZVhWM0Zn?oc=5","date":"2022-03-03","type":"pipeline","source":"bizjournals.com","summary":"Former Liquidia CEO launches new venture targeting kidney disease - bizjournals.com","headline":"Former Liquidia CEO launches new venture targeting kidney disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQX3FnU1ZSYVRsYWU2Sk9sLUY2SFo5cTBmY3V5dElKLVZQdXJySmRpckp3VFZhMTV0Xzg3RlZzcVNEQXlCTENSUEJUZ3pOcUlpdkhjaF9VcjlzZjFLeGJZWnRmWE40VkNON2tTZW5MN2tqQ2FwU1R0UnVUa0hJWTYyaVJZYzM5OVFOR0pVbmZLelAtOEF6SUZsaHQ2MEtwUWlyYWJsNzhYYXhGTE81ZVBmOXdVWGloMW50Z3NncU5VLVp1d25aYzBZRlVzTElrQVBHcEZVWl9YdTdxLWEwWTlaYXJMN3N6Q3ZPcnc?oc=5","date":"2022-03-01","type":"pipeline","source":"PR Newswire","summary":"Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease - PR Newswire","headline":"Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}